Inovio Pharmaceuticals, Inc.
(NASDAQ : INO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading INO News...
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
BDXBecton, Dickinson and Company
0.26%184.601.3%$592.86m
BCRC. R. Bard, Inc.
-0.08%307.321.6%$560.81m
MDTMedtronic PLC
0.94%84.020.6%$357.65m
TMOThermo Fisher Scientific Inc.
0.25%171.951.0%$304.50m
ISRGIntuitive Surgical, Inc.
2.69%893.777.5%$273.23m
ABTAbbott Laboratories
1.24%43.700.8%$260.99m
ZBHZimmer Biomet Holdings, Inc.
0.08%117.761.7%$214.10m
EWEdwards Lifesciences Corporation
0.94%113.951.2%$210.37m
BSXBoston Scientific Corporation
1.42%26.791.1%$192.31m
BAXBaxter International Inc.
0.71%57.621.7%$182.99m
ALGNAlign Technology, Inc.
-0.18%138.186.2%$163.01m
SYKStryker Corporation
1.30%138.591.3%$150.46m
HOLXHologic, Inc.
0.22%43.101.6%$136.17m
IDXXIDEXX Laboratories, Inc.
0.37%162.233.6%$105.71m
WATWaters Corporation
-0.07%175.383.3%$104.46m

Company Profile

Inovio Pharmaceuticals, Inc. is a bio pharmaceutical company. It develops active DNA immunotherapies for cancer and infectious diseases. The company's portfolio of immune therapies includes SynCon immunotherapies and electroporation delivery systems. Its pipeline consists vgx-3100, ino-3122, ino-3106, pennvax-b and pennvax-g. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA.